Detalhe da pesquisa
1.
CD4+ effector T cells accelerate Alzheimer's disease in mice.
J Neuroinflammation
; 18(1): 272, 2021 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34798897
2.
Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8+ T Cells in a Diameter-Dependent Manner.
Mol Pharm
; 14(5): 1469-1481, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28319404
3.
Immune senescence in aged APP/PS1 mice.
NeuroImmune Pharm Ther
; 2(3): 317-330, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023614
4.
Multipolymer microsphere delivery of SARS-CoV-2 antigens.
Acta Biomater
; 158: 493-509, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581007
5.
Amyloid-ß specific regulatory T cells attenuate Alzheimer's disease pathobiology in APP/PS1 mice.
Mol Neurodegener
; 18(1): 97, 2023 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111016
6.
Prodrug Therapies for Infectious and Neurodegenerative Diseases.
Pharmaceutics
; 14(3)2022 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35335894
7.
Protective Effect of CP690550 in MPTP-Induced Parkinson's Like Behavioural, Biochemical and Histological Alterations in Mice.
Neurotox Res
; 40(2): 564-572, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35366203
8.
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease.
Clin Transl Med
; 12(7): e958, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802825
9.
Development of an extended half-life GM-CSF fusion protein for Parkinson's disease.
J Control Release
; 348: 951-965, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35738463
10.
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson's disease.
NeuroImmune Pharm Ther
; 1(1): 43-50, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38407500
11.
Europium-Doped Cerium Oxide Nanoparticles for Microglial Amyloid Beta Clearance and Homeostasis.
ACS Chem Neurosci
; 13(8): 1232-1244, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35312284
12.
Defining the Immune Responses for SARS-CoV-2-Human Macrophage Interactions.
bioRxiv
; 2021 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34268510
13.
Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions.
Front Immunol
; 12: 741502, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671355
14.
A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention.
J Neuroimmune Pharmacol
; 16(2): 270-288, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33544324
15.
Nanocarrier vaccines for SARS-CoV-2.
Adv Drug Deliv Rev
; 171: 215-239, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428995
16.
Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection.
Int J Pharm
; 565: 242-257, 2019 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077762